Archive

DOJ Catch of the Week -- Novo Nordisk Inc.

Posted 09/8/17

By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Novo Nordisk Inc. On Tuesday, the company agreed to pay $58.65 million to settle charges it violated the False Claims Act and Food, Drug, and Cosmetic Act by failing to comply with the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) for its Type II diabetes medication Victoza. The New Jersey based...

Tagged in: Catch of the Week, FCA Federal, FDA Fraud, Pharma Fraud,

U.S. Government Joins Constantine Cannon Case Brought By U.K. Whistleblower against British Retailer for Customs Fraud

Posted 09/8/17

By the C|C Whistleblower Lawyer Team Constantine Cannon LLP is pleased to announce that the U.S. Government has intervened in its client's whistleblower case against Pure Collection Ltd., a Harrogate, England-based e-retailer of luxury cashmere and apparel. The Government also brought claims against Pure's current acting CEO, Samantha Harrison. The whistleblower lawsuit, among one of the first whistleblower cases...

Tagged in: Customs Fraud, FCA Federal, International Whistleblowers, Whistleblower Case,

Two Bay Area Companies for Developmentally Disabled Settle Whistleblower Charges of Overbilling

Posted 08/29/17

By the C|C Whistleblower Lawyer Team Two Bay Area companies and their owners agreed to pay roughly $2 million to settle charges they violated the False Claims Act by overbilling the government in a program designed to serve Californians with developmental disabilities. The government, and the whistleblower who originated the action -- Beverly McCaffery -- alleged that Alternative Learning Center, its president...

Tagged in: FCA Federal, Healthcare Fraud, Whistleblower Rewards,

Eye Surgery Provider Settles FCA Kickback Allegations for $12M

Posted 08/23/17

By the C|C Whistleblower Lawyer Team Sightpath Medical, Inc., its parent TLC Vision Corp., and its former CEO James Tiffany have agreed to pay $12 million to resolve allegations, originally brought by a whistleblower, that they defrauded the government by billing it for eye surgery products and services tainted by illegal kickbacks to physicians. According to the Justice Department’s press release, Sightpath...

Tagged in: Anti-Kickback and Stark, FCA Federal, Provider Fraud, Whistleblower Case, Whistleblower Rewards,

In Their Own Words -- Weinreb

Posted 08/21/17

--“Taxpayers rightly expect companies like Mylan that receive payments from taxpayer-funded programs to scrupulously follow the rules. We will continue to protect the integrity of Medicaid and ensure a level playing field for pharmaceutical companies. ”

Statement of Acting United States Attorney William D. Weinreb commenting on the $465 million settlement in an FCA case against Mylan Inc.

Tagged in: FCA Federal, In Their Own Words,

DOJ Catch of the Week -- Mylan

Posted 08/18/17

By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Mylan Inc. and Mylan Specialty L.P. Yesterday, the pharmaceutical companies agreed to pay $465 million to settle charges they violated the False Claims Act by purposely misclassifying EpiPen as a generic drug to avoid paying higher Medicaid rebates. In announcing the settlement, the government stressed its "unwavering...

Tagged in: Catch of the Week, Drug and DME Pricing, FCA Federal, Medicaid, Pharma Fraud, Whistleblower Eligibility, Whistleblower Rewards,

Mortgage Fraud Whistleblower Gets Over $9 Million

Posted 08/9/17

By the C|C Whistleblower Lawyer Team Yesterday, the U.S. Department of Justice (DOJ) announced a nearly $75 million settlement with PHH Mortgage Corporation regarding the company’s failure to meet origination, underwriting, and quality-control regulations promulgated by Department of Housing and Urban Development’s (HUD) Federal Housing Administration (FHA), the U.S. Department of Veterans Affairs, the Federal...

Tagged in: FCA Federal, Housing and Mortgage Fraud, Whistleblower Rewards,

Celgene to Pay $280M to Resolve Fraud Allegations

Posted 07/26/17

By the C|C Whistleblower Lawyer Team Pharmaceutical manufacturer Celgene Corp. agreed to pay $280 million to settle claims that it illegally promoted two cancer drugs, Thalomid and Revlimid, for unapproved uses. The case was filed by a former Celgene sales representative under the False Claims Act, which allows individuals to sue to recover government dollars and share in any recovery. The New York Times reports...

Tagged in: Anti-Kickback and Stark, FCA Federal, FCA State, Healthcare Fraud, Medicaid, Medicare, Off-Label and Unapproved Use, Pharma Fraud, Whistleblower Case, Whistleblower Rewards,

DOJ Catch of The Week -- Foundations Health Solutions

Posted 07/21/17

By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Foundations Health Solutions Inc., Olympia Therapy Inc. and Tridia Hospice Care Inc. On Monday, these Ohio-based companies, comprising one of the largest nursing home operations in the state, and their executives Brian Colleran and Daniel Parker, agreed to pay roughly $19.5 million to resolve allegations that they...

Tagged in: Anti-Kickback and Stark, Catch of the Week, FCA Federal, Home Health and Hospice, Lack of Medical Necessity, Whistleblower Rewards,

Ninth Circuit Finds Materiality in the Face of Continued Government Payment

Posted 07/14/17

By Rosie Dawn Griffin Earlier this month, the U.S. Court of Appeals for the Ninth Circuit revived United States ex rel. Campie v. Gilead Scis., a False Claims Act (FCA) suit against pharmaceutical giant Gilead Sciences and, in doing so, provided the qui tam bar with additional guidance on how the lower courts will interpret the Supreme Court’s emphasis on materiality in Universal Health Services, Inc. v....

Tagged in: FCA Federal, FCA Materiality, FDA Fraud, Other Government Health Programs, Pharma Fraud, Whistleblower Case,

Contact

Click here for a confidential contact or call:

DOJ Catch of the Week -- Novo Nordisk Inc.

U.S. Government Joins Constantine Cannon Case Brought By U.K. Whistleblower against British Retailer for Customs Fraud

Two Bay Area Companies for Developmentally Disabled Settle Whistleblower Charges of Overbilling

Eye Surgery Provider Settles FCA Kickback Allegations for $12M

In Their Own Words -- Weinreb

--“Taxpayers rightly expect companies like Mylan that receive payments from taxpayer-funded programs to scrupulously follow the rules. We will continue to protect the integrity of Medicaid and ensure a level playing field for pharmaceutical companies. ”

DOJ Catch of the Week -- Mylan

Mortgage Fraud Whistleblower Gets Over $9 Million

Celgene to Pay $280M to Resolve Fraud Allegations

DOJ Catch of The Week -- Foundations Health Solutions

Ninth Circuit Finds Materiality in the Face of Continued Government Payment

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: